$AGEN
AGENUS INC Stock $agen

$agen Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-K Financial Statement

#000162828015001809 Filed on March 16, 2015

Income Statement

Concept	2015 Q1	2014 Q4	2014
Revenue	$3.953M	$1.619M	$6.977M
YoY Change	448.27%	311.96%	129.13%
Cost Of Revenue		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Gross Profit		$1.620M	$6.977M
YoY Change		315.38%	178.09%
Gross Profit Margin		100.06%	100.0%
Selling, General & Admin	$5.490M	$5.040M	$21.20M
YoY Change	0.92%	49.55%	46.21%
% of Gross Profit		311.11%	303.84%
Research & Development	$9.220M	$7.370M	$22.35M
YoY Change	106.15%	127.47%	71.85%
% of Gross Profit		454.94%	320.31%
Depreciation & Amortization	$450.0K	$560.0K	$1.100M
YoY Change	66.67%	300.0%	87.71%
% of Gross Profit		34.57%	15.77%
Operating Expenses	$9.220M	$18.94M	$22.35M
YoY Change	106.15%	186.54%	71.85%
Operating Profit	-$18.29M	-$17.32M	-$43.32M
YoY Change	86.19%	178.46%	73.42%
Interest Expense	$396.9K	-$300.0K	$1.262M
YoY Change	11.54%	-14.29%	-47.86%
% of Operating Profit
Other Income/Expense, Net	-$52.95K	-$8.350M	$2.096M
YoY Change	-100.54%	-1143.75%	-178.43%
Pretax Income	-$18.74M	-$25.98M	-$42.49M
YoY Change	2828.13%	349.48%	41.28%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$18.74M	-$25.98M	-$42.49M
YoY Change	5149.58%	349.68%	41.28%
Net Earnings / Revenue	-474.1%	-1604.57%	-608.91%
Basic Earnings Per Share	-$0.28
Diluted Earnings Per Share	-$281.1K	-$413.2K	-$710.7K
COMMON SHARES
Basic Shares Outstanding	70.76M shares	62.68M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q1	2014 Q4	2014
SHORT-TERM ASSETS
Cash & Short-Term Investments	$79.30M	$40.20M	$40.20M
YoY Change	7.89%	46.72%	46.72%
Cash & Equivalents	$79.30M	$25.71M	$25.70M
Short-Term Investments	$0.00	$14.50M	$14.50M
Other Short-Term Assets	$747.4K	$640.0K	$2.300M
YoY Change	68.42%	292.62%	155.56%
Inventory	$88.20K	$95.70K	$100.0K
Prepaid Expenses	$2.480M	$1.248M
Receivables	$2.534M	$463.0K	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$85.15M	$42.67M	$42.70M
YoY Change	13.15%	51.45%	51.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.880M	$5.997M	$6.000M
YoY Change	42.17%	115.33%	114.29%
Goodwill	$18.27M	$17.87M
YoY Change	-6.96%	594.7%
Intangibles	$6.815M	$6.774M
YoY Change	-14.79%
Long-Term Investments
YoY Change
Other Assets	$1.207M	$1.217M	$1.200M
YoY Change	-5.31%	-6.68%	-7.69%
Total Long-Term Assets	$32.17M	$31.86M	$31.80M
YoY Change	-2.64%	378.26%	381.82%
TOTAL ASSETS
Total Short-Term Assets	$85.15M	$42.67M	$42.70M
Total Long-Term Assets	$32.17M	$31.86M	$31.80M
Total Assets	$117.3M	$74.53M	$74.50M
YoY Change	8.33%	113.94%	114.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.973M	$1.711M	$1.700M
YoY Change	136.28%	104.97%	112.5%
Accrued Expenses	$6.254M	$5.502M	$5.500M
YoY Change	33.09%	30.52%	30.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$423.8K	$1.257M	$1.300M
YoY Change	-85.23%	-64.27%	-62.86%
Total Short-Term Liabilities	$21.00M	$9.229M	$9.200M
YoY Change	46.1%	-10.36%	-10.68%
LONG-TERM LIABILITIES
Long-Term Debt	$11.10M	$4.769M	$4.800M
YoY Change	109.43%	-10.01%	-9.43%
Other Long-Term Liabilities	$2.986M	$2.800M	$37.50M
YoY Change	12.48%	66.73%	58.23%
Total Long-Term Liabilities	$2.986M	$7.570M	$42.30M
YoY Change	12.48%	350.67%	45.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.00M	$9.229M	$9.200M
Total Long-Term Liabilities	$2.986M	$7.570M	$42.30M
Total Liabilities	$23.98M	$16.80M	$51.50M
YoY Change	40.86%	40.28%	31.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$710.0M	-$691.3M
YoY Change	9.38%	6.5%
Common Stock	$708.4K	$627.2K
YoY Change	13.83%	72.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00
YoY Change		-100.0%
Treasury Stock Shares	0.000 shares	0.000 shares
Shareholders Equity	$46.26M	$23.02M	$23.00M
YoY Change
Total Liabilities & Shareholders Equity	$117.3M	$74.53M	$74.50M
YoY Change	8.33%	113.94%	114.08%

Cashflow Statement

Concept	2015 Q1	2014 Q4	2014
OPERATING ACTIVITIES
Net Income	-$18.74M	-$25.98M	-$42.49M
YoY Change	5149.58%	349.68%	41.28%
Depreciation, Depletion And Amortization	$450.0K	$560.0K	$1.100M
YoY Change	66.67%	300.0%	87.71%
Cash From Operating Activities	$3.295M	-$10.50M	-$38.23M
YoY Change	-132.55%	89.53%	95.74%
INVESTING ACTIVITIES
Capital Expenditures	$323.6K	-$1.710M	$2.820M
YoY Change	87.47%	2750.0%	246.61%
Acquisitions
YoY Change
Other Investing Activities	$14.53M	$10.00K	-$13.99M
YoY Change	2749.02%		-3208.89%
Cash From Investing Activities	$14.21M	-$1.700M	-$16.81M
YoY Change	4056.73%	2733.33%	4525.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$36.10M	-730.0K	$52.81M
YoY Change	-35.44%	-126.45%	104.85%
NET CHANGE
Cash From Operating Activities	$3.295M	-10.50M	-$38.23M
Cash From Investing Activities	$14.21M	-1.700M	-$16.81M
Cash From Financing Activities	$36.10M	-730.0K	$52.81M
Net Change In Cash	$53.60M	-12.93M	-$2.237M
YoY Change	16.21%	355.28%	-138.02%
FREE CASH FLOW
Cash From Operating Activities	$3.295M	-$10.50M	-$38.23M
Capital Expenditures	$323.6K	-$1.710M	$2.820M
Free Cash Flow	$2.972M	-$8.790M	-$41.05M
YoY Change	-128.86%	60.4%	101.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	agen	Aggregategrossproceedsavailable Aggregategrossproceedsavailable	150000000	USD
CY2012	agen	Business Combination Contingent Consideration Initial Issue BusinessCombinationContingentConsiderationInitialIssue	0	USD
CY2013	agen	Business Combination Contingent Consideration Initial Issue BusinessCombinationContingentConsiderationInitialIssue	0	USD
CY2014	agen	Business Combination Contingent Consideration Initial Issue BusinessCombinationContingentConsiderationInitialIssue	9721000	USD
CY2012	agen	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	0	USD
CY2013	agen	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	291517	USD
CY2014	agen	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	0	USD
CY2008Q1	agen	Class Of Warrant Or Right Exercisable Term ClassOfWarrantOrRightExercisableTerm	P9Y6M
CY2009Q3	agen	Class Of Warrant Or Right Non Exercisable Term ClassOfWarrantOrRightNonExercisableTerm	P6M
CY2008Q1	agen	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P10Y
	agen	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P4Y
CY2013Q4	agen	Clinical Trials ClinicalTrials	1021000	USD
CY2014Q4	agen	Clinical Trials ClinicalTrials	245000	USD
CY2012	agen	Clinical Trials Expense ClinicalTrialsExpense	654000	USD
CY2013	agen	Clinical Trials Expense ClinicalTrialsExpense	2720000	USD
CY2014	agen	Clinical Trials Expense ClinicalTrialsExpense	895000	USD
CY2013Q4	agen	Contingent Royalty ContingentRoyalty	18799141	USD
CY2014Q4	agen	Contingent Royalty ContingentRoyalty	15279000	USD
CY2013Q2	agen	Contingent Royalty ContingentRoyalty	19100000	USD
CY2012	agen	Conversion Of Notes Payable To Future Royalties ConversionOfNotesPayableToFutureRoyalties	0	USD
CY2013	agen	Conversion Of Notes Payable To Future Royalties ConversionOfNotesPayableToFutureRoyalties	19090658	USD
CY2014	agen	Conversion Of Notes Payable To Future Royalties ConversionOfNotesPayableToFutureRoyalties	0	USD
CY2014Q4	agen	Cumulative Payments For Clinical Trials CumulativePaymentsForClinicalTrials	51100000	USD
CY2013Q4	agen	Deferredtaxassetscontingentroyaltyconsideration Deferredtaxassetscontingentroyaltyconsideration	7384000	USD
CY2014Q4	agen	Deferredtaxassetscontingentroyaltyconsideration Deferredtaxassetscontingentroyaltyconsideration	3370000	USD
CY2014Q4	agen	Estimate Of Total Payments For Clinical Trials EstimateOfTotalPaymentsForClinicalTrials	53500000	USD
CY2012	agen	Financing Of Property And Equipment FinancingOfPropertyAndEquipment	-38744	USD
CY2013	agen	Financing Of Property And Equipment FinancingOfPropertyAndEquipment	-53297	USD
CY2014	agen	Financing Of Property And Equipment FinancingOfPropertyAndEquipment	-39156	USD
CY2014Q4	agen	Finite Lived Intangible Assets Amortization Expense Year Fifteen FiniteLivedIntangibleAssetsAmortizationExpenseYearFifteen	37000	USD
CY2014Q4	agen	Finite Lived Intangible Assets Amortization Expense Years Five Through Fourteen FiniteLivedIntangibleAssetsAmortizationExpenseYearsFiveThroughFourteen	290000	USD
CY2012	agen	Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest	1499981	USD
CY2013	agen	Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest	0	USD
CY2014	agen	Issuance Of Senior Secured Convertible Notes As Payment In Kind For Interest IssuanceOfSeniorSecuredConvertibleNotesAsPaymentInKindForInterest	0	USD
CY2012	agen	Net Operating Loss Expirations NetOperatingLossExpirations	-821000	USD
CY2013	agen	Net Operating Loss Expirations NetOperatingLossExpirations	-1778000	USD
CY2014	agen	Net Operating Loss Expirations NetOperatingLossExpirations	-996000	USD
CY2013Q4	agen	Other Ltd OtherLTD	5347690	USD
CY2014Q4	agen	Other Ltd OtherLTD	4769359	USD
CY2012	agen	Paymentofcontingentroyaltyobligation Paymentofcontingentroyaltyobligation	0	USD
CY2013	agen	Paymentofcontingentroyaltyobligation Paymentofcontingentroyaltyobligation	0	USD
CY2014	agen	Paymentofcontingentroyaltyobligation Paymentofcontingentroyaltyobligation	-400000	USD
CY2014Q4	agen	Purchase Price Consideration Fair Value Disclosure PurchasePriceConsiderationFairValueDisclosure	16420000	USD
CY2012	agen	Reclassification Of Liability Classified Option Grants ReclassificationOfLiabilityClassifiedOptionGrants	-31945	USD
CY2013	agen	Reclassification Of Liability Classified Option Grants ReclassificationOfLiabilityClassifiedOptionGrants	-4347	USD
CY2014	agen	Reclassification Of Liability Classified Option Grants ReclassificationOfLiabilityClassifiedOptionGrants	-487227	USD
CY2012	agen	Research And Development Revenue ResearchAndDevelopmentRevenue	14470895	USD
CY2013	agen	Research And Development Revenue ResearchAndDevelopmentRevenue	1627343	USD
CY2014	agen	Research And Development Revenue ResearchAndDevelopmentRevenue	6473227	USD
CY2012	agen	Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue	2100000	USD
CY2013	agen	Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue	1600000	USD
CY2014	agen	Share Based Compensation Arrangement By Share Based Payment Award Options Vested During Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedDuringPeriodIntrinsicValue	200000	USD
CY2012	agen	Share Based Compensation Expense ShareBasedCompensationExpense	4304000	USD
CY2013	agen	Share Based Compensation Expense ShareBasedCompensationExpense	4128000	USD
CY2014	agen	Share Based Compensation Expense ShareBasedCompensationExpense	4672000	USD
CY2014Q4	agen	Shares Available For Sale Through Sales Agent SharesAvailableForSaleThroughSalesAgent	10000000	shares
CY2008Q1	agen	Shares Issued In Private Placements Shares SharesIssuedInPrivatePlacementsShares	1451450	shares
CY2008Q2	agen	Shares Issued In Private Placements Shares SharesIssuedInPrivatePlacementsShares	1166666	shares
CY2009Q3	agen	Shares Issued In Private Placements Shares SharesIssuedInPrivatePlacementsShares	730994	shares
CY2009Q3	agen	Shares Issued In Private Placements Shares SharesIssuedInPrivatePlacementsShares	833333	shares
CY2013	agen	Shares Issued In Private Placements Shares SharesIssuedInPrivatePlacementsShares	9472494	shares
CY2007Q3	agen	Stock Issued During Period Price Per Share StockIssuedDuringPeriodPricePerShare	18.48
CY2013	agen	Stock Issued During Periodfor Extinguishmentof Debtshares StockIssuedDuringPeriodforExtinguishmentofDebtshares	12416689	shares
CY2012	agen	Vesting Of Nonvested Shares Value VestingOfNonvestedSharesValue	0	USD
CY2013	agen	Vesting Of Nonvested Shares Value VestingOfNonvestedSharesValue	0	USD
CY2014	agen	Vesting Of Nonvested Shares Value VestingOfNonvestedSharesValue	0	USD
CY2012	agen	Weighted Average Number Of Shares Outstanding Basic And Diluted1 WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1	23628903	shares
CY2013	agen	Weighted Average Number Of Shares Outstanding Basic And Diluted1 WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1	29765547	shares
CY2014	agen	Weighted Average Number Of Shares Outstanding Basic And Diluted1 WeightedAverageNumberOfSharesOutstandingBasicAndDiluted1	59753552	shares
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001098972
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	70759935	shares
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q2	dei	Entity Public Float EntityPublicFloat	147300000	USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	AGENUS INC
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	834740	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1710946	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1200	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4215221	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5501527	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1121000	USD
CY2013Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1635000	USD
CY2014Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3134000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27637443	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28369982	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1970420	USD
CY2014Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P13Y
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	644571866	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	715667633	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4074814	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4054561	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4604713	USD
CY2013Q4	us-gaap	Assets Assets	34835481	USD
CY2014Q4	us-gaap	Assets Assets	74526528	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	28174578	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	42670301	USD
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.18
CY2014	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.72
CY2013	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-39065000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-43282000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	6949000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	7183000	USD
CY2012	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2013	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2014	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-6699300	USD
CY2013Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	16420300	USD
CY2012	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2013	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2014	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	514470	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10747951	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21468269	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27351969	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25714519	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10720318	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5883700	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1637450	USD
CY2014Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	40224089	USD
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	4.41
CY2009Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	694441	shares
CY2009Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	778982	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	500000	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36391191	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67720065	shares
CY2007Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	270562	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	666666	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	363912	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	14393000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	212577000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	234149000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	300000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	627201	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12116506	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33232451	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44660426	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	671972	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	536118	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9600000	USD
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6300000	USD
CY2014	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P2Y
CY2012	us-gaap	Debt Issuance Costs DebtIssuanceCosts	0	USD
CY2013	us-gaap	Debt Issuance Costs DebtIssuanceCosts	-177802	USD
CY2014	us-gaap	Debt Issuance Costs DebtIssuanceCosts	0	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1660679	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	184421	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3193809	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3009568	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	212877000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	235198000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-422000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	300000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1049000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	177589000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	192223000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	10153000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	14230000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15059000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	13674000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1471000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	48000	USD
CY2014	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.60
CY2012	us-gaap	Depreciation Depreciation	1600000	USD
CY2013	us-gaap	Depreciation Depreciation	600000	USD
CY2014	us-gaap	Depreciation Depreciation	1121712	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1622736	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	586343	USD
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1583960	USD
CY2012	us-gaap	Dividends Preferred Stock DividendsPreferredStock	791735	USD
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3159782	USD
CY2014	us-gaap	Dividends Preferred Stock DividendsPreferredStock	203832	USD
CY2012	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	395250	USD
CY2014	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	460963	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.51
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.40
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.12
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.71
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	0	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	0	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	599525	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2014	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M
CY2014	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.102
CY2013Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	18799000	USD
CY2014Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	15279000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3579159	USD
CY2012	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	USD
CY2013	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	USD
CY2014	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	201092	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	462248	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	528000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	402000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	478000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7236000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6773722	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	11000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	9000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	773000	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-11026	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-59110	USD
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-4583	USD
CY2012	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2013	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	355500	USD
CY2014	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3300000	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3322657	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11465092	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14483835	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21249710	USD
CY2013Q4	us-gaap	Goodwill Goodwill	2572203	USD
CY2014Q4	us-gaap	Goodwill Goodwill	17869023	USD
CY2014	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	16891000	USD
CY2014	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-1594000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2944000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9561000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14043000	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	726000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3850000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10225000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-14445000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	640000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	143000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-795000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	26000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	102000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	117000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-581000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-1359000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-642000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-181848	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	189638	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-45902	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	552334	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-551134	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1200	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2707613	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1474171	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3610811	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4050	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-16022	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	95700	USD
CY2012	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	542349	USD
CY2013	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1916467	USD
CY2014	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1316169	USD
CY2012	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-747982	USD
CY2013	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-183473	USD
CY2014	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	685696	USD
CY2012	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	9637	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	112505	USD
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	254045	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6773722	USD
CY2012	us-gaap	Interest Expense InterestExpense	4694701	USD
CY2013	us-gaap	Interest Expense InterestExpense	2419798	USD
CY2014	us-gaap	Interest Expense InterestExpense	1261626	USD
CY2012	us-gaap	Interest Paid InterestPaid	1573554	USD
CY2013	us-gaap	Interest Paid InterestPaid	579650	USD
CY2014	us-gaap	Interest Paid InterestPaid	675391	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	95700	USD
CY2014Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	14510000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1600000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2100000	USD
CY2014Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1000000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34835481	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74526528	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10295873	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9229423	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3518550	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1257178	USD
CY2012	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	0	USD
	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	5600000	USD
CY2013	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	5580124	USD
CY2014	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	0	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9811158	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25780165	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52810710	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-103442	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-363520	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16813100	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1012602	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19532945	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38234585	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-11324771	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-5835000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-11142000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-7319000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-5777000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-30072669	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-357000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-8042000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-8109000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-25978000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-42486174	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12116506	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8842000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11193000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7370000	USD
CY2013Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5827000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-33232451	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-409000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8091000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8161000	USD
CY2014Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26029000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42690006	USD
CY2013Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4089000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	7000000	USD
CY2014Q4	us-gaap	Nonfinancial Liabilities Fair Value Disclosure NonfinancialLiabilitiesFairValueDisclosure	31699000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	110473	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2672759	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2096334	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-6740543	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-24980112	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-43320882	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	13734000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1924000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1647000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1601000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1548000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1728000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5286000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	438000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	685000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	162997	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1102964	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1303855	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1216795	USD
CY2012	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1778184	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1970420	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-194000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1764	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	66683	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	575351	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1679671	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2800491	USD
CY2012	us-gaap	Other Noncash Expense OtherNoncashExpense	3141475	USD
CY2013	us-gaap	Other Noncash Expense OtherNoncashExpense	1820787	USD
CY2014	us-gaap	Other Noncash Expense OtherNoncashExpense	619846	USD
CY2012	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	592875	USD
CY2013	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
CY2014	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	460963	USD
CY2012	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2013	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	14507806	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	103442	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	813520	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2819764	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	658412	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1247548	USD
CY2011Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6300000	USD
CY2012	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	10000000	USD
CY2014	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2009Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000	USD
CY2009Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000	USD
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	78574	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	104010	USD
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	251911	USD
CY2012	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10464203	USD
CY2013	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	26462810	USD
CY2014	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	56792252	USD
CY2012	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-100000	USD
CY2013	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-555556	USD
CY2014	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-3333334	USD
CY2012	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	USD
CY2013	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	450000	USD
CY2014	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30422000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34367000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2784845	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5996687	USD
CY2012	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	399000	USD
CY2013	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	481000	USD
CY2014	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	365000	USD
CY2015	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	376000	USD
CY2012	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2013	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	10000000	USD
CY2014	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10564195	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13005366	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22349327	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-649092036	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-691306343	USD
CY2012	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2013	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2014	us-gaap	Revenue From Grants RevenueFromGrants	504228	USD
CY2012	us-gaap	Revenues Revenues	15960716	USD
CY2013Q1	us-gaap	Revenues Revenues	1109000	USD
CY2013Q2	us-gaap	Revenues Revenues	807000	USD
CY2013Q3	us-gaap	Revenues Revenues	736000	USD
CY2013Q4	us-gaap	Revenues Revenues	393000	USD
CY2013	us-gaap	Revenues Revenues	3045207	USD
CY2014Q1	us-gaap	Revenues Revenues	721000	USD
CY2014Q2	us-gaap	Revenues Revenues	3074000	USD
CY2014Q3	us-gaap	Revenues Revenues	1563000	USD
CY2014Q4	us-gaap	Revenues Revenues	1619000	USD
CY2014	us-gaap	Revenues Revenues	6977455	USD
CY2008Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	18.00
CY2008Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	18.00
CY2009Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	13.68
CY2009Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	12.00
CY2012	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1489821	USD
CY2013	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1417864	USD
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	0	USD
CY2014Q4	us-gaap	Security Deposit SecurityDeposit	204000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	4303961	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	4127786	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	4672256	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	20207	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	3.59
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.99
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.93
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	48239	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.26
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.96
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.86502
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8422
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.009
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0149
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0174
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	45000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	401754	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	464941	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3277700	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.94
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.42
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.87
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3788900	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.72
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.40
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3197167	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	5.63
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3307644	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6000984	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.51
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.00
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.16
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.41
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.02
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1057765	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M27D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M21D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y9M15D
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	14509570	USD
CY2014	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	3334079	shares
CY2011Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2287581	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	48381	shares
CY2012	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2013	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2014	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	10102259	USD
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2012	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	52193	USD
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	88880	USD
CY2014	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	106597	USD
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10464203	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16990316	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	4.51	USD
CY2012	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2013	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	11275000	USD
CY2014	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	953765	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	2906664	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	26381	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15130	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	145314	USD
CY2014	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	0	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-20830965	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-17600157	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-4480703	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	23018387	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	43490	shares
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	324792	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5649000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5778000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	90000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	39000	USD
CY2014	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the FASB issued Accounting Standards Update No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists", ("ASU 2013-11"). ASU 2013-11 amends ASC 740, "Income Taxes", by providing guidance on the financial statement presentation of an unrecognized benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU 2013-11 does not affect the recognition or measurement of uncertain tax positions under ASC 740. ASU 2013-11 is effective for interim and annual periods beginning after December 15, 2013, with early adoption permitted. The adoption of ASU 2013-11 did not have an impact on our consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, ("ASU 2014-09"). ASU 2014-09 amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. This new standard provides a five step framework whereby revenue is recognized when promised goods or services are transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires enhanced disclosures pertaining to revenue recognition in both interim and annual periods. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2016. We are currently evaluating the potential impact that ASU 2014-09 may have on our consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, ("ASU 2014-15"). ASU 2014-15 describes how an entity should assess its ability to meet obligations and sets rules for how this information should be disclosed in the financial statements. The standard provides guidance that will be used along with existing auditing standards. ASU 2014-15 applies to all entities and is effective for the annual period ending after December 15, 2016, and for annual and interim periods thereafter with early adoption permitted. We are currently evaluating the potential impact that ASU 2014-15 may have on our consolidated financial statements and related disclosures.</font></div></div>
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base those estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-15-001809-index-headers.html	Edgar Link	pending
0001628280-15-001809-index.html	Edgar Link	pending
0001628280-15-001809.txt	Edgar Link	pending
0001628280-15-001809-xbrl.zip	Edgar Link	pending
a10kexhibitincycolla.gif	Edgar Link	pending
agen-123113xex1022xincytec.htm	Edgar Link	pending
agen-123114ex321.htm	Edgar Link	pending
agen-123114xex1021.htm	Edgar Link	pending
agen-123114xex108.htm	Edgar Link	pending
agen-123114xex21.htm	Edgar Link	pending
agen-123114xex23.htm	Edgar Link	pending
agen-123114xex311.htm	Edgar Link	pending
agen-123114xex312.htm	Edgar Link	pending
agen-123114xex421.htm	Edgar Link	pending
agen-12312012x10k.jpg	Edgar Link	pending
agen-12312014x10k.htm	Edgar Link	pending
agen-20141231.xml	Edgar Link	completed
agen-20141231.xsd	Edgar Link	pending
agen-20141231_cal.xml	Edgar Link	unprocessable
agen-20141231_def.xml	Edgar Link	unprocessable
agen-20141231_lab.xml	Edgar Link	unprocessable
agen-20141231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AGEN
AGENUS INC Stock $agen

2015 Q1 Form 10-K Financial Statement

#000162828015001809 Filed on March 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGEN AGENUS INC Stock $agen

2015 Q1 Form 10-K Financial Statement

#000162828015001809 Filed on March 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGEN
AGENUS INC Stock $agen